secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-09-25T20:45:25+00:00
Accession:  0001493152-26-044346
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

Co-Diagnostics annual meeting fails quorum twice; adjourned again to Sept 30, 2026
--------------------------------------------------------------------------------

- Annual Meeting held September 3, 2026 did not achieve a quorum and could not transact business; meeting adjourned.
- Adjourned meeting on September 24, 2026 also failed to reach quorum, so no shareholder votes were taken.
- Meeting adjourned again to September 30, 2026 at 9:00 a.m. Mountain Time at company offices, 2401 S. Foothill Dr, Ste. D, Salt Lake City, Utah.
- Valid proxies submitted earlier remain valid for the reconvened meeting unless properly changed or revoked; items are per the July 21, 2026 definitive proxy.
- CEO Dwight Egan signed the report dated September 24, 2026; no voting results for any proposal were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226044346/0001493152-26-044346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226044346/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-044346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer